Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $80.74 and traded as high as $86.01. Arkema shares last traded at $85.62, with a volume of 2,080 shares.
Arkema Stock Performance
The business has a 50 day moving average price of $81.52 and a 200 day moving average price of $84.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.11 and a quick ratio of 1.54. The stock has a market capitalization of $6.83 billion, a PE ratio of 17.96, a PEG ratio of 0.53 and a beta of 1.30.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Recommended Stories
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.